Trial Profile
Induction of Mucosal Tolerance to E-Selectin for the Secondary Prevention of Stroke
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Recombinant E-selectin (Primary)
- Indications Stroke
- Focus Therapeutic Use
- 30 May 2014 New trial record